ENOV — Enovis Share News
0.000.00%
HealthcareMicro Cap
Brief: Enovis Announces Third Quarter 2023 Results And Raises Full-Year Outlook
Brief: Enovis Corp Sees FY Rev To Organically Grow 7.4%-7.6% From Prior Year Versus Previous Expectations Of 7%-7.5% Growth
Brief: Enovis Outlook FY Adjusted EPS USD 2.3-2.4
Brief: Enovis Q3 Adjusted EPS USD 0.56 Vs. IBES Estimate USD 0.54
Enovis Corp expected to post earnings of 54 cents a share - Earnings Preview
Brief: Enovis Announces Pricing Of Private Offering Of $400 Mln Of 3.875% Convertible Senior Notes Due 2028
J&J Q3 results positive for orthopedic, cardio device makers - brokerages
J&J Q3 results positive for orthopedic, cardio device makers - brokerages
U.S. STOCKS ON THE MOVE-Starbucks, Williams-Sonoma, FedEx
U.S. STOCKS ON THE MOVE-Soligenix, Enovis, Lifeway Foods
Enovis rises after $850 million deal for LimaCorporate
Enovis to buy prosthetic implants maker LimaCorporate for $850 mln (updated)
Brief: Enovis To Acquire LimaCorporate S.P.A.
Enovis to buy prosthetic implants maker LimaCorporate for $850 mln -sources
Enovis Corp reports results for the quarter ended in June - Earnings Summary
Brief: Enovis Q2 Adjusted EPS USD 0.61 Vs. IBES Estimate USD 0.52
Enovis Corp expected to post earnings of 52 cents a share - Earnings Preview
Enovis Corp reports results for the quarter ended in March - Earnings Summary
Brief: Enovis Announces First Quarter 2023 Results